DNA Sequencer Quantum Said to Win $20.5 Million Venture Funding

Quantum Biosystems Inc., an Osaka-based company developing a faster genome sequencer, raised 2.4 billion yen ($20.5 million) in venture-capital funding from firms including Jafco Co., people with knowledge of the matter said.

To continue reading this article you must be a Bloomberg Professional Service Subscriber.